A recent report from the U.S.-China Economic and Security Review Commission examines China’s biotechnology development, HealthITSecurity reports. Among the key findings, the report notes the Chinese government has identified health care–related data as important to the development of biotech and made its collection a national priority. The report notes, “Chinese biotechnology companies are acquiring technologies crucial to advancement in the field as well as amassing large collections of clinical and genetic data on U.S. residents.” In addition to recommendations for how the U.S. can respond to the developments, researchers emphasized the need to better protect U.S. health care data.
Full Story